Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
基本信息
- 批准号:8235748
- 负责人:
- 金额:$ 30.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAngiotensin IIAnimal ModelAntiatherogenicAortaAtherosclerosisBlood CirculationBlood PressureBlood VesselsCardiovascular DiseasesCell Adhesion MoleculesCell CommunicationCell Differentiation processCell ProliferationCell modelCellsChronic DiseaseDataDevelopmentEndothelial CellsEndothelinGTP-Binding ProteinsGenesGoalsGuanosine TriphosphateHypertensionHypertrophyHypoxiaInbred SHR RatsLeadLesionLeukocytesLungMediatingMediator of activation proteinMembraneModificationMolecular ModelsMusMuscle ContractionNitric OxideNitric Oxide PathwayNuclearPathway interactionsPatientsPhosphorylationPlayPreventionProductionProteinsPulmonary HypertensionRattusRegulationResearchRho-associated kinaseRoleS-NitrosothiolsSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesTherapeuticThrombinThromboplastinThromboxane A2TissuesVascular remodelingVasoconstrictor AgentsVasodilationbaseblood pressure regulationcell motilitydesignin vivoinflammatory markerinsightkinase inhibitormigrationmolecular modelingmyosin phosphatasenovelpressurepreventrhorhoA GTP-Binding Proteinvascular inflammationvasoconstriction
项目摘要
Small GTP binding proteins of the ras superfamily are recognized to play a key role in
development of cardiovascular disease. In this regard Rho proteins are particularly
important. For example RhoA signaling through Rho-kinases regulate diverse vascular
functions including smooth muscle contraction and migration, leukocyte-endothelial cell
interactions, tissue factor expression, cell differentiation and cell proliferation. The Rho
pathway is activated by vasoactive agonist including angiotensin II, endothelin I,
thrombin, thromboxane A2, etc., whose over-activity is commonly associated with
cardiovascular disease and contributes to systemic and pulmonary hypertension,
vascular inflammation, and atherosclerosis. Rho pathway activation can be seen early in
development of hypertension and Rho-kinase inhibitors relax vascular tissues, reduce
blood pressure and inhibit smooth muscle proliferation and vascular remodeling. In
contrast to RhoA activation, derivatives of nitric oxide (NO) reduce blood pressure,
inhibit thrombogenesis, inhibit smooth muscle proliferation and generally play an anti-
atherogenic role. S-nitrosothiols occuring in the circulation may be particulary important
for these effects. Interactions between the RhoA pathway and NO production have
recently emerged with the demonstration that decreased NO synthesis leads to
increased RhoA signaling. While the mechanisms for this effect is not known, we have
recently found that S-nitrosothiols derived from NO, oxidize and reversibly inhibit GDP-
GTP exchange in purified RhoA protein, inhibit translocation of RhoA to the membrane
and block modification of downstream targets of Rho-kinase. The potential implications
of these findings is that NO-derivatives such as S-nitrosothiols oppose mechanisms
dependent on RhoA/Rho-kinase activation. Thus our hypothesis is that S-nitrosothiols
negatively regulate Rho signaling protecting the vascularture from pro-atherogenic
mechanisms. We will investigate this hypothesis using molecular, cellular and animal
models. Data gathered from these studies will have important implications and suggest
new mechanisms through which nitric oxide regulates vascular function. In addtion,
pharmacologic approaches based on S-nitrosothiols are feasible and may lead to new
therapies which may include acute treatment of hypertensive disorders and chronic
treatment of complications associated with atherosclerosis.
ras超家族的小GTP结合蛋白被认为在
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reductive ligation mediated one-step disulfide formation of S-nitrosothiols.
- DOI:10.1021/ol101863s
- 发表时间:2010-09-17
- 期刊:
- 影响因子:5.2
- 作者:Zhang, Jiming;Li, Sheng;Zhang, Dehui;Wang, Hua;Whorton, A. Richard;Xian, Ming
- 通讯作者:Xian, Ming
Reaction based fluorescent probes for hydrogen sulfide.
- DOI:10.1021/ol3008183
- 发表时间:2012-04-20
- 期刊:
- 影响因子:5.2
- 作者:Liu C;Peng B;Li S;Park CM;Whorton AR;Xian M
- 通讯作者:Xian M
Direct methods for detection of protein S-nitrosylation.
- DOI:10.1016/j.ymeth.2013.04.018
- 发表时间:2013-08-01
- 期刊:
- 影响因子:4.8
- 作者:Devarie-Baez, Nelmi O.;Zhang, Dehui;Li, Sheng;Whorton, A. Richard;Xian, Ming
- 通讯作者:Xian, Ming
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A RICHARD WHORTON其他文献
A RICHARD WHORTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A RICHARD WHORTON', 18)}}的其他基金
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7748012 - 财政年份:2009
- 资助金额:
$ 30.89万 - 项目类别:
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7997191 - 财政年份:2009
- 资助金额:
$ 30.89万 - 项目类别:
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7580056 - 财政年份:2009
- 资助金额:
$ 30.89万 - 项目类别:
CELLULAR REDOX CONTROL AND NITRIC OXIDE SIGNALING
细胞氧化还原控制和一氧化氮信号传导
- 批准号:
2907116 - 财政年份:1999
- 资助金额:
$ 30.89万 - 项目类别:
CELLULAR REDOX CONTROL AND NITRIC OXIDE SIGNALING
细胞氧化还原控制和一氧化氮信号传导
- 批准号:
6184716 - 财政年份:1999
- 资助金额:
$ 30.89万 - 项目类别:
CELLULAR REDOX CONTROL AND NITRIC OXIDE SIGNALING
细胞氧化还原控制和一氧化氮信号传导
- 批准号:
6537477 - 财政年份:1999
- 资助金额:
$ 30.89万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 30.89万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 30.89万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 30.89万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 30.89万 - 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
- 批准号:
440714 - 财政年份:2020
- 资助金额:
$ 30.89万 - 项目类别:
Fellowship Programs